01.12.2012 Views

Norsk Patenttidende nr 07/05 - Patentstyret

Norsk Patenttidende nr 07/05 - Patentstyret

Norsk Patenttidende nr 07/05 - Patentstyret

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(51) Klasse : A61K 031/546<br />

A61K 047/10<br />

A61P 031/04<br />

(21) Søknads<strong>nr</strong> : 20042271<br />

(22) Inndag : 2004.06.01<br />

(41) Allm.tilgj : 2004.<strong>07</strong>.22<br />

(30) Prioritet : 2001.11.30, US, 338536<br />

2002.<strong>07</strong>.26, US, 398932<br />

(86) Int.inndag : 2002.11.13<br />

(86) Int.søknads<strong>nr</strong> : PCT/IB02/04743<br />

(24) Løpedag 2002.11.13<br />

(71) Søker<br />

Pfizer Products Inc , Eastern Point Road, CT06340<br />

GROTON, US<br />

(74) Fullmektig<br />

Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />

(72) Oppfinner<br />

Brian Scott Bronk, c/o Pfizer Global Research and<br />

Development, Eastern Point Road, GROTON, CT06340, US<br />

Roger Nelson Kimball, Pfizer Global Research and<br />

Development, Eastern Point Road, GROTON, CT06340, US<br />

Renuka Devi Reddy, Pfizer Global Research and<br />

Development, Eastern Point Road, GROTON, CT06340, US<br />

Evgenyi Yur'evich Shalaev, c/o Pfizer Global Research and<br />

Development, Eastern Point Road, GROTON, CT06340, US<br />

Simon Edvard Blanchflower, c/o Pfizer Global Research and<br />

Development, Eastern Point Road, GROTON, CT06340, US<br />

(54) Benevnelse<br />

Formuleringer som inneholder en cefalosporinforbindelse og<br />

deres anvendelse for behandling av bakterielle infeksjoner i<br />

katter og hunder<br />

(51) Klasse : A61K 031/546<br />

A61K 009/00<br />

(21) Søknads<strong>nr</strong> : 20042620<br />

(22) Inndag : 2004.06.22<br />

(41) Allm.tilgj : 2004.06.22<br />

(30) Prioritet : 2001.11.23, EP, 01500277<br />

(86) Int.inndag : 2002.11.21<br />

(86) Int.søknads<strong>nr</strong> : PCT/EP02/13150<br />

(24) Løpedag 2002.11.21<br />

(71) Søker<br />

Glaxo Group Ltd , Glaxo Wellcome House, Berkeley<br />

Avenue, UB60NN GREENFORD, MIDDLESEX, GB<br />

(74) Fullmektig<br />

Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />

(72) Oppfinner<br />

Matilde Ibanez Fernandez, c/o GlaxoSmithKline, Severo<br />

Ochoa 2, TRES CANTOS, 28760, ES<br />

Emilio Sanz Garriz, c/o GlaxoSmithKline, Severo Ochoa 2,<br />

TRES CANTOS, 28760, ES<br />

(54) Benevnelse<br />

Belagte partikulære cefuroxim axetil-blandinger<br />

allment tilgjengelige patentsøknader (A) 20<strong>05</strong>.02.14 - <strong>nr</strong> <strong>07</strong>/<strong>05</strong><br />

34<br />

(51) Klasse : A61K 031/337<br />

A61K 031/4745<br />

A61K 031/7068<br />

(21) Søknads<strong>nr</strong> : 20042609<br />

(22) Inndag : 2004.06.22<br />

(41) Allm.tilgj : 2004.06.22<br />

(30) Prioritet : 2001.11.23, EP, 01127401<br />

2001.12.19, EP, 01130245<br />

2002.03.12, EP, 020<strong>05</strong>298<br />

(86) Int.inndag : 2002.11.18<br />

(86) Int.søknads<strong>nr</strong> : PCT/EP02/12911<br />

(24) Løpedag 2002.11.18<br />

(71) Søker<br />

Chugai Seiyaku KK , 5-1, Ukima 5-chome, Kita-ku, 115-8543<br />

TOKYO, JP<br />

(74) Fullmektig<br />

Tandbergs Patentkontor AS , Postboks 7085 Majorstua,<br />

0306 OSLO, NO<br />

(72) Oppfinner<br />

Hideo Ishitsuka, 5-15-2<strong>07</strong> Kaigan 2-chome, Minato-ku,<br />

TOKYO, 1<strong>05</strong>-0022, JP<br />

Hisafumi Okabe, c/o Chugai Seiyaku K K , 200, Kajiwara,<br />

KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />

Nobuo Shimma, c/o Chugai Seiyaku KK , 200 Kajiwara,<br />

KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />

Takuo Tsukuda, c/o Chugai Seiyaku K K , 200, Kajiwara,<br />

KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />

Isao Umeda, c/o Chugai Seiyaku K K , 200, Kajiwara,<br />

KAMAKURA-SHI, KANAGAWA, 247-8530, JP<br />

(54) Benevnelse<br />

Fremgangsmåte for identifisering av tumormålrettede<br />

enzymer<br />

(51) Klasse : A61K 045/06<br />

A61P 029/00<br />

A61P 017/06<br />

A61P 035/04<br />

(21) Søknads<strong>nr</strong> : 20041618<br />

(22) Inndag : 2004.04.21<br />

(41) Allm.tilgj : 2004.<strong>07</strong>.22<br />

(30) Prioritet : 2001.10.23, JP, 324435/01<br />

(86) Int.inndag : 2002.03.18<br />

(86) Int.søknads<strong>nr</strong> : PCT/JP02/02552<br />

(24) Løpedag 2002.03.18<br />

(71) Søker<br />

Ono Pharmaceutical Co Ltd , 1-5, Doshomachi 2-chome,<br />

Chuo-ku, 541-8526 OSAKA-SHI, OSAKA, JP<br />

(74) Fullmektig<br />

JK Thorsens Patentbureau AS , Postboks 9276 Grønland,<br />

0134 OSLO, NO<br />

(72) Oppfinner<br />

Shiro Shibayama, c/o Minase Research Inst., Ono Pharma<br />

Co Ltd, 1-1, Sakurai 3-chome, Shimamoto, MISHIMA-GUN,<br />

OSAKA, 618-8585, JP<br />

Yoshikazu Takaoka, c/o Minase Research Inst., Ono<br />

Pharma Co Ltd, 1-1, Sakurai 3-chome, Shimamoto,<br />

MISHIMA-GUN, OSAKA, 618-8585, JP<br />

Haruo Imawaka, c/o Minase Research Institute, Ono<br />

Pharmaceutical Co Ltd, 1-1, Sakurai 3-chome, Shimamotocho,<br />

MISHIMA-GUN, OSAKA, 618-8585, JP<br />

(54) Benevnelse<br />

Legemidler omfattende en kombinasjon av<br />

triazaspiro[5,5]undekanderivat med cytokrom P450 isozyn<br />

3A4 inhibitor og/eller P-glykoproeininhibitor

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!